First Light Asset Management, LLC Castle Biosciences Inc Transaction History

First Light Asset Management, LLC

  • $1.28 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
SELL
$11.66 - $26.0 $17,396 - $38,792
-1,492 Reduced 0.92%
160,126 $2.2 Million
Q1 2023

May 15, 2023
BUY
$19.47 - $28.49 $272 - $398
14 Added 0.01%
161,618 $3.67 Million
Q4 2022

Feb 14, 2023
SELL
$18.08 - $30.0 $29,289 - $48,600
-1,620 Reduced 0.99%
161,604 $3.8 Million
Q3 2022

Nov 14, 2022
BUY
$22.51 - $34.32 $3.67 Million - $5.6 Million
163,224 New
163,224 $4.26 Million

Others Institutions Holding CSTL

# of Institutions
162
Shares Held
25.3M
Call Options Held
82.2K
Put Options Held
150K
View Full List

About CASTLE BIOSCIENCES INC

CSTL Quotes by TradingView
  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $559M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track First Light Asset Management, LLC Portfolio

Follow First Light Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on First Light Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email